Enmetazobactam

SKU: orb1308700

Description

Enmetazobactam (AAI101) is a novel extended-spectrum β-lactamase inhibitor used in research to combat multi-drug resistant Gram-negative bacteria. It is studied in vitro and in vivo to restore the efficacy of β-lactam antibiotics like cefepime against infections caused by ESBL-producing Enterobacterales.

Research Area

Infectious Disease & Virology

Images & Validation

−

Key Properties

−

CAS Number	1001404-83-6
MW	314.32
Purity	99.78% (May vary between batches)
Formula	C₁₁H₁₄N₄O₅S
SMILES	[H][C@@]12CC(=O)N1[C@@H](C([O-])=O)[C@](C)(Cn1cc[n+](C)n1)S2(=O)=O
Target	Antibacterial
Solubility	10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (12.73 mM);DMSO:113.3 mg/mL (360.46 mM)

Bioactivity

−

In Vivo

Against a panel of 20 mostly carbapenemase-producing cefepime-nonsusceptible strains of the family Enterobacteriaceae, we evaluated the MICs of cefepime in the presence of various fixed Enmetazobactam concentrations (1, 2, 4, 8, and 16 mg/liter) and the in vivo efficacy of simulated human doses of cefepime and cefepime-Enmetazobactam in a neutropenic murine thigh infection model.At 2 h after inoculation, mice were dosed with regimens that provided a profile mimicking the free drug concentration-time profile observed in humans given cefepime at 2 g every 8 h (q8h;as a 30-min infusion) or cefepime-Enmetazobactam at 2 g/0.5 g q8h (as a 30-min infusion).Efficacy was determined by calculation of the change in thigh bacterial density (log10 number of CFU) after 24 h relative to the starting inoculum (0 h). After 24 h, bacterial growth of 2.7 0.1 log10 CFU (mean standard error) was observed in control animals.Efficacy for cefepime monotherapy was observed against only 3 isolates, whereas increases in bacterial density similar to that in the control animals were noted for the remaining 17 strains (all with cefepime MICs of 64 mg/liter).The humanized cefepime-Enmetazobactam dosing regimen resulted in bacterial reductions of 0.5 log10 CFU for 12 of the 20 strains.

In Vitro

Enmetazobactam, a novel extended-spectrum β-lactamase inhibitor.Of the 223 cefepime non-susceptible isolates, 95% were ceftazidime non-susceptible, 49% ertapenem non-susceptible, 57% piperacillin/tazobactam non-susceptible, 90% were multidrug-resistant (resistant to 3 drug classes), 22% produced carbapenemases, and 67% produced ESBLs.Addition of Enmetazobactam restored the activity of cefepime such that the MIC50 was reduced from >64 mg/L for cefepime to 0.13 mg/L for cefepime/Enmetazobactam, supporting its continued development treatment for infections caused by these organisms.Enmetazobactam shows potent activity against specific resistance phenotypes with MIC50 and MIC90 of 0.125 mg/L and 64 mg/L.Cefepime-Enmetazobactam MICs decreases with increasing concentrations of Enmetazobactam (over the range from 1 to 16 mg/L) for most strains.which is demonstrating a concentration dependence of Enmetazobactam on restoration of the antibacterial activity of the cephalosporin.

Storage & Handling

−

Storage	keep away from moisture,store under nitrogen,store at low temperature \| Pure form: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

inhibit, Enmetazobactam, Inhibitor, Bacterial, AAI 101, AAI101, AAI-101

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

23653540 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

Enmetazobactam (orb1308700)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

CAS Number:	1379594-98-5
MW:	442.23
Formula:	C₁₁H₁₅IN₄O₅S

Enmetazobactam

Description

Research Area

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Alternative Names

Similar Products

Enmetazobactam iodide [orb2566316]

Quality Guarantee

Compound Identifiers

Key Properties

Documents Download

Request a Document

Protocol Information

Enmetazobactam (orb1308700)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors